Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Agomelatine for Prevention of Poststroke Depression
NCT05426304Phase 4Unknown
- Sponsor
- The First Affiliated Hospital of Sun Yat-sen University
- Start
- Oct 2022
- Primary completion
- May 2024
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of agomelatine in major depressive disorder (MDD), sponsored by The First Affiliated Hospital of Sun Yat-sen University. Status: unknown.
02
Drugs
agomelatine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT05426304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05426304.